Meeting report VLPNPV: Session 10: Virus-like particle and nano-particle vaccines

Christopher Ladd Effio; Juergen Hubbuch

doi:10.4161/hv.29840

Meeting report VLPNPV: Session 10: Virus-like particle and nano-particle vaccines

Hum Vaccin Immunother. 2014;10(10):3080-2. doi: 10.4161/hv.29840.

Authors

Christopher Ladd Effio¹, Juergen Hubbuch

Affiliation

¹ a Karlsruhe Institute of Technology; Institute of Process Engineering in Life Sciences; Section IV: Biomolecular Separation Engineering ; Engler-Bunte-Ring , Karlsruhe.

Abstract

Session 10 of the Virus-like Particle and Nano-Particle Vaccines meeting 2014 focused on new methods in vaccine technology to accelerate process development, manufacturing and quality control. The session presented new ways of quantifying and characterizing particle samples. In addition platform approaches for production and purification of virus-like particle (VLP) vaccines were highlighted.

Keywords: analytics; high-throughput screening; influenza; particle characterization; purification.

Publication types

Congress

MeSH terms

Epitopes / immunology
Humans
Influenza Vaccines / immunology*
Influenza, Human / prevention & control
Malaria Vaccines / immunology*
Malaria, Falciparum / immunology
Malaria, Falciparum / prevention & control
Nanoparticles
Plasmodium falciparum / immunology
Respiratory Syncytial Virus Vaccines / immunology*
Respiratory Syncytial Viruses / immunology
Vaccines, Virus-Like Particle / immunology*
Vaccines, Virus-Like Particle / therapeutic use*

Substances

Epitopes
Influenza Vaccines
Malaria Vaccines
Respiratory Syncytial Virus Vaccines
Vaccines, Virus-Like Particle